Differential Risk of Incident Alzheimer’s Disease Dementia in Stable Versus Unstable Patterns of Subjective Cognitive Decline
The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
BACKGROUND: It is unknown whether longitudinal stability versus instability in subjective cognitive decline (SCD) is a modifying factor of the association between SCD and risk of incident Alzheimer's disease (AD) dementia. OBJECTIVE: We tested the modifying role of temporal stability of the SCD report on AD dementia risk in cognitively normal elderly individuals. METHODS: We analyzed data of 1,990 cognitively normal participants from the longitudinal AgeCoDe Study. We assessed SCD with/without associated worries both at baseline and first follow-up 18 months later. Participants were then classified either as (a) Controls (CO, with no SCD at both baseline and follow-up 1, n = 613), (b) inconsistent SCD (with SCD reported only at baseline or at follow-up 1, n = 637), (c) consistent SCD but without/or with inconsistent worries (n = 610) or (d) consistent SCD with worries (n = 130). We estimated incident AD dementia risk over up to 6 years for each group with Cox-Proportional Hazard Regression analyses adjusted for age, gender, education, ApoE4 status, and depression. RESULTS: Compared to CO, inconsistent SCD was not associated with increased risk of incident AD dementia. In contrast, risk was doubled in the group of consistent SCD without/ with inconsistent worries, and almost 4-fold in the group of consistent SCD with worries. These results could be replicated when using follow-up 1 to follow-up 2 response patterns for group definition. CONCLUSION: These findings suggest that longitudinal stability versus instability is an important modifying factor of the association between SCD and AD dementia risk. Worrisome SCD that is also consistently reported over time is associated with greatly increased risk of AD dementia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“One study showed those who over time consistently reported subjective cognitive decline that they found worrisome were at higher risk for developing Alzheimer's dementia.255”
From 2023 Alzheimer's disease facts and figures (2023) · cites this paper as [255]
In the citing paper
“One study showed those who consistently reported subjective cognitive decline that they found worrisome were at higher risk for developing Alzheimer's dementia.”
From 2024 Alzheimer's disease facts and figures (2024) · cites this paper as [281]
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Development and validation of a geriatric depression screening scale: a preliminary report
Yesavage, J. A., Brink, T. L., Rose, T. L., Lum, O., Huang, V., Adey, M., & Leirer, V. O. (1982) · Journal of Psychiatric Research · doi:10.1016/0022-3956(82)90033-4 · Cited by 15,025
Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J., Montine, T. J., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.003 · Cited by 7,155 · cited 1×
“, in the preclinical stage III of AD [10] characterized by the presence of amyloidosis and neurodegeneration on a biomarker level, and subtle cognitive decline on a clinical/behavioral level [35].”
The Global Deterioration Scale for assessment of primary degenerative dementia
(1982) · American Journal of Psychiatry · doi:10.1176/ajp.139.9.1136 · Cited by 4,986
Román, G. C., Tatemichi, T. K., Erkinjuntti, T., Cummings, J. L., Masdeu, J. C., Garcia, J. H., Amaducci, L., Orgogozo, J.-M., Brun, A., Hofman, A., et al. (1993) · Neurology · doi:10.1212/wnl.43.2.250 · Cited by 4,921
Jack, C. R., Knopman, D. S., Jagust, W. J., Petersen, R. C., Weiner, M. W., Aisen, P. S., Shaw, L. M., Vemuri, P., Wiste, H. J., Weigand, S. D., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70291-0 · Cited by 4,396
Blessed, G., Tomlinson, B. E., & Roth, M. (1968) · British Journal of Psychiatry · doi:10.1192/bjp.114.512.797 · Cited by 4,117 · cited 1×
“Dementiadiagnosisin patients who were not personally interviewed was based on the Global Deterioration Scale [32] and the Blessed Dementia Rating scale [33].”
Jessen, F., Amariglio, R. E., van Boxtel, M., Breteler, M., Ceccaldi, M., Chételat, G., Dubois, B., Dufouil, C., Ellis, K. A., van der Flier, W. M., et al. (2014) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.01.001 · Cited by 3,014 · cited 8×
“An instable SCD report is, however, compatible with a variety of other etiological conditions of SCD that, unlikeAD,canalsobeofepisodic,ratherthanchronic orprogressivenature[10].”
InfluentialSelf-citationPathological verification of ischemic score in differentiation of dementias
Rosen, W. G., Terry, R. D., Fuld, P. A., Katzman, R., & Peck, A. (1980) · Annals of Neurology · doi:10.1002/ana.410070516 · Cited by 1,273
Cited by
2023 Alzheimer's disease facts and figures
(2023) · Alzheimer's & Dementia · doi:10.1002/alz.13016 · Cited by 3,212
2024 Alzheimer's disease facts and figures
(2024) · Alzheimer's & Dementia · doi:10.1002/alz.13809 · Cited by 2,536
2019 Alzheimer’s disease facts and figures.
Alzheimer's Association (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2019.01.010 · Cited by 2,461
2020 Alzheimer's disease facts and figures
(2020) · Alzheimer's & Dementia · doi:10.1002/alz.12068 · Cited by 2,353
2022 Alzheimer's disease facts and figures
(2022) · Alzheimer's & Dementia · doi:10.1002/alz.12638 · Cited by 2,341
2021 Alzheimer's disease facts and figures
(2021) · Alzheimer's & Dementia · doi:10.1002/alz.12328 · Cited by 2,201
2018 Alzheimer's disease facts and figures
Alzheimer's Association (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.02.001 · Cited by 1,912
The characterisation of subjective cognitive decline
Jessen, F., Amariglio, R. E., Buckley, R. F., van der Flier, W. M., Han, Y., Molinuevo, J. L., Rabin, L., Rentz, D. M., Rodriguez-Gomez, O., Saykin, A. J., et al. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(19)30368-0 · Cited by 1,389
Self-citation2017 Alzheimer's disease facts and figures
(2017) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2017.02.001 · Cited by 1,311
Subjective Cognitive Decline in Preclinical Alzheimer's Disease
Rabin, L. A., Smart, C. M., & Amariglio, R. E. (2017) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-032816-045136 · Cited by 590
2025 Alzheimer's disease facts and figures
(2025) · Alzheimer's & Dementia · doi:10.1002/alz.70235 · Cited by 474
Subjective cognitive decline and risk of MCI: The Mayo Clinic Study of Aging
van Harten, A. C., Mielke, M. M., Swenson-Dravis, D. M., Hagen, C. E., Edwards, K. K., Roberts, R. O., Geda, Y. E., Knopman, D. S., & Petersen, R. C. (2018) · Neurology · doi:10.1212/wnl.0000000000005863 · Cited by 312
Functional cognitive disorders: a systematic review
McWhirter, L., Ritchie, C., Stone, J., & Carson, A. (2020) · The Lancet Psychiatry · doi:10.1016/s2215-0366(19)30405-5 · Cited by 240
Miebach, L., Wolfsgruber, S., Polcher, A. A., Peters, O., Menne, F., Luther, K., Incesoy, E. I., Priller, J., Spruth, E. J., Altenstein, S., et al. (2019) · Alzheimer s Research & Therapy · doi:10.1186/s13195-019-0515-y · Cited by 141
Self-citationLiew, T. M. (2020) · Alzheimer s Research & Therapy · doi:10.1186/s13195-020-00673-8 · Cited by 142
Functional Disintegration of the Default Mode Network in Prodromal Alzheimer’s Disease
Dillen, K. N. H., Jacobs, H. I. L., Kukolja, J., Richter, N., von Reutern, B., Onur, Ö. A., Langen, K.-J., & Fink, G. R. (2017) · Journal of Alzheimer’s Disease · doi:10.3233/jad-161120 · Cited by 106
Li, X., Wang, X., Su, L., Hu, X., & Han, Y. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-028188 · Cited by 106
“Progression of mild cognitive impairment to Alzheimer's disease: improved diagnostic value of the combined use of N200 latency and beta-amyloid(1-42) levels.”
BackgroundPET Neuroimaging of Alzheimer's Disease: Radiotracers and Their Utility in Clinical Research
Bao, W., Xie, F., Zuo, C., Guan, Y., & Huang, Y. H. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.624330 · Cited by 102
Trajectories of subjective cognitive decline, and the risk of mild cognitive impairment and dementia
Liew, T. M. (2020) · Alzheimer s Research & Therapy · doi:10.1186/s13195-020-00699-y · Cited by 94
“Such argument has had some precedence in the literature, whereby Persistent SCD—when co-occurring with worries about SCD [44] or reported by informant [45] (both of which are features of SCD plus)—were shown to further increase the risk of neurocognitive disorders.”
BackgroundResultSubjective Cognitive Decline Is Associated with Greater White Matter Hyperintensity Volume
van Rooden, S., van den Berg‐Huysmans, A. A., Croll, P. H., Labadie, G., Hayes, J. M., Viviano, R. P., van der Grond, J., Rombouts, S. A. R. B., & Damoiseaux, J. S. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180285 · Cited by 65
“AD is the most common form of dementia, and therefore the most common cause of mild cognitive impairment (MCI) and possibly SCD [16, 17].”
BackgroundThe Role of Magnetoencephalography in the Early Stages of Alzheimer’s Disease
López-Sanz, D., Serrano, N., & Maestú, F. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00572 · Cited by 59
Characteristics of subjective cognitive decline associated with amyloid positivity
Janssen, O., Jansen, W. J., Vos, S. J. B., Boada, M., Parnetti, L., Gabryelewicz, T., Fladby, T., Molinuevo, J. L., Villeneuve, S., Hort, J., et al. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12512 · Cited by 61
Self-citationSources of Response Bias in Cognitive Self-Report Items: “Which Memory Are You Talking About?”
Hill, N. L., Mogle, J. A., Bratlee‐Whitaker, E., Gilmore‐Bykovskyi, A. L., Bhargava, S., Bhang, I., Sweeder, L., Tiwari, P. A., & Haitsma, K. S. V. (2018) · The Gerontologist · doi:10.1093/geront/gny087 · Cited by 62
Subjective Cognitive Decline and APOE ɛ4: A Systematic Review
Ali, J. I., Smart, C. M., & Gawryluk, J. R. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180248 · Cited by 53
Li, D., Liu, Y., Zeng, X., Xiong, Z., Yao, Y., Liang, D., Qu, H., Xiang, H., Yang, Z., Nie, L., et al. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200843 · Cited by 46
for the EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders, Drzezga, A. E., Altomare, D., Festari, C., Arbizu, J., Orini, S., Herholz, K., Nestor, P. J., Agosta, F., Bouwman, F. H., et al. (2018) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-018-4032-1 · Cited by 43
Marchant, N. L., Barnhofer, T., Coueron, R., Wirth, M., Lutz, A., Arenaza-Urquijo, E. M., Collette, F., Poisnel, G., Demnitz-King, H., Schild, A.-K., et al. (2021) · Psychotherapy and Psychosomatics · doi:10.1159/000515669 · Cited by 40
Self-citationSu, H., Zhou, Y., Sun, Y., & Cai, Y. (2022) · Psychology Health & Medicine · doi:10.1080/13548506.2022.2125165 · Cited by 46
Automated Brain MRI Volumetry Differentiates Early Stages of Alzheimer’s Disease From Normal Aging
Zhao, W., Luo, Y., Zhao, L., Mok, V., Su, L., Yin, C., Sun, Y., Lu, J., Shi, L., & Han, Y. (2019) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988719862637 · Cited by 40
Prediction of dementia of Alzheimer type by different types of subjective cognitive decline
Jessen, F., Kleineidam, L., Wolfsgruber, S., Bickel, H., Brettschneider, C., Fuchs, A., Kaduszkiewicz, H., König, H., Mallon, T., Mamone, S., et al. (2020) · Alzheimer's & Dementia · doi:10.1002/alz.12163 · Cited by 37
“Secondly, we constructed longitudinal SCD subtypes (3).”
Self-citationSannemann, L., Schild, A., Altenstein, S., Bartels, C., Brosseron, F., Büerger, K., Cosma, N. C., Fließbach, K., Freiesleben, S. D., Glanz, W., et al. (2020) · Alzheimer s Research & Therapy · doi:10.1186/s13195-020-00701-7 · Cited by 41
“Results from the AgeCoDe study showed that in subjects with longitudinally stable SCD, the risk of incident dementia was doubled compared to healthy controls without SCD [23].”
BackgroundSelf-citationKleineidam, L., Wagner, M., Guski, J., Wolfsgruber, S., Miebach, L., Bickel, H., König, H., Weyerer, S. B., Lühmann, D., Kaduszkiewicz, H., et al. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12785 · Cited by 41
“We distinguished between (1) persistently low DS (BL DS–/BL DS–), (2) decreasing DS (BL DS+/BL DS–), (3) increasing DS (BL DS– /BL DS+), and (4) persistently high DS (BL DS+/BL DS+).”
BackgroundSelf-citationCognitive complaints in age-related chronic conditions: A systematic review
Hill, N. L., Bhargava, S., Brown, M. J., Kim, H., Bhang, I., Mullin, K. T., Phillips, K., & Mogle, J. A. (2021) · PLoS ONE · doi:10.1371/journal.pone.0253795 · Cited by 40
Fredriksen‐Goldsen, K. I., Jung, H. H., Kim, H., Petros, R., & Emlet, C. A. (2021) · Journal of Aging and Health · doi:10.1177/08982643211046466 · Cited by 38
Schwarz, C., Lange, C., Benson, G. S., Horn, N., Wurdack, K., Lukas, M., Buchert, R., Wirth, M., & Flöel, A. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.675583 · Cited by 41
“Several studies indicate SCD as an at-risk stage for future cognitive decline and eventual clinical progression to mild cognitive impairment (MCI) and dementia due to Alzheimer’s disease (AD) (Jessen et al., 2014b, 2020; Koppara et al., 2015; Wolfsgruber et al., 2016).”
BackgroundWion, R. K., Hill, N. L., Bell, T. R., Mogle, J. A., Yates, J., & Bhang, I. (2021) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/08919887211023591 · Cited by 32
López-Sanz, D., Bruña, R., Delgado-Losada, M. L., López-Higes, R., Marcos-Dolado, A., Maestú, F., & Walter, S. (2019) · Alzheimer's Research & Therapy · doi:10.1186/s13195-019-0502-3 · Cited by 29
Baiden, P., Cassidy, J., Panisch, L. S., LaBrenz, C. A., & Onyeaka, H. (2021) · Aging & Mental Health · doi:10.1080/13607863.2021.2017848 · Cited by 30
Wion, R. K., Hill, N. L., DePasquale, N., Mogle, J. A., & Bratlee‐Whitaker, E. (2019) · Activities Adaptation & Aging · doi:10.1080/01924788.2019.1651188 · Cited by 29
“…that SCI may indicate a subtle onset of cognitive decline, including preclinical AD (Jessen, 2014; Rönnlund, Sundström, Adolfsson, & Nilsson, 2015; Wolfsgruber et al., 2016), it is possible that lower levels of physical activity contribute to the onset of cognitive symptoms, such as SCI, over…”
BackgroundRobertson, F., & Jacova, C. (2022) · The Gerontologist · doi:10.1093/geront/gnac109 · Cited by 31
Jester, D. J., Andel, R., Čechová, K., Laczó, J., Lerch, O., Marková, H., Nikolai, T., Vyhnálek, M., & Hort, J. (2020) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617720001046 · Cited by 27
“Other factors may be at play too, such as temporal stability in SCD (Wolfsgruber et al., 2016), cognitive reserve (Mazzeo et al., 2019), and apolipoprotein E ϵ4 (Ali, Smart, & Gawryluk, 2018).”
BackgroundGarcía, M. A., Warner, D. F., García, C., Downer, B. G., & Raji, M. A. (2021) · Innovation in Aging · doi:10.1093/geroni/igab039 · Cited by 25
Sohrabi, H. R., Weinborn, M., Laske, C., Bates, K. A., Christensen, D., Taddei, K., Rainey‐Smith, S. R., Brown, B. M., Gardener, S. L., Laws, S. M., et al. (2018) · International Psychogeriatrics · doi:10.1017/s1041610218001072 · Cited by 21
Numbers, K. T., Lam, B. C. P., Crawford, J. D., Kochan, N. A., Sachdev, P. S., & Brodaty, H. (2021) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.5594 · Cited by 24
Macoir, J., Tremblay, P., & Hudon, C. (2022) · Behavioral Sciences · doi:10.3390/bs12120491 · Cited by 21
“According to longitudinal studies, SCD and MCI are associated with a similar increased risk of AD [66,67].”
Dementia Worry and Neuropsychological Performance in Healthy Older Adults
Caughie, C. A., Bean, P. S., Tiede, P., Cobb, J., McFarland, C. W., & Hall, S. (2020) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/acaa057 · Cited by 24
Hopper, S., Hammond, N. G., Taler, V., & Stinchcombe, A. (2022) · Gerontology · doi:10.1159/000524280 · Cited by 21
Möllers, T., Stocker, H. R., Perna, L., Rujescu, D., Holleczek, B., Schöttker, B., & Brenner, H. (2022) · Age and Ageing · doi:10.1093/ageing/afac113 · Cited by 16
Abdulrahman, H., Richard, E., van Gool, W. A., van Charante, E. P. M., & van Dalen, J. W. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-215191 · Cited by 14
“SMC and IADL-I are common in the aging population, with reports suggesting a prevalence of up to 50% for both symptoms in community-dwelling older people [12, 13].”
BackgroundYu, M., Guan, H., Fang, Y., Yue, L., & Liu, M. (2022) · Lecture notes in computer science · doi:10.1007/978-3-031-16431-6_3 · Cited by 13
Sánchez‐Benavides, G., Salvadó, G., Arenaza‐Urquijo, E. M., Grau‐Rivera, O., Suárez‐Calvet, M., Milà‐Alomà, M., Gónzalez‐de‐Echávarri, J. M., Minguillón, C., Crous‐Bou, M., Niñerola‐Baizán, A., et al. (2020) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12127 · Cited by 15
Drouin, S. M., McFall, G. P., & Dixon, R. A. (2021) · Neuropsychology · doi:10.1037/neu0000784 · Cited by 14
Li, C., Hong, Y., Yang, X. W., Zeng, X., Ocepek‐Welikson, K., Eimicke, J. P., Kong, J., Sano, M. C., Zhu, C. W., Neugroschl, J. A., et al. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12804 · Cited by 13
BACE1 as an early biomarker and its relevance to risk factors for Alzheimer’s disease
Ohno, M. (2025) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2025.111475 · Cited by 13
Apolipoprotein E e4 Allele Is Associated with Subjective Cognitive Decline: A Meta-Analysis
Zhang, T., Liu, S., Zhang, Y., Guan, Y., Wang, X., Zhao, L., Shi, Z., Yue, W., Zhang, Y., Liu, S., et al. (2017) · Neuroepidemiology · doi:10.1159/000482018 · Cited by 13
Carmasin, J. S., Roth, R. M., Rabin, L. A., Englert, J. J., Flashman, L. A., & Saykin, A. J. (2020) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/acaa129 · Cited by 10
“Longitudinal data over approximately 5 years suggested that stability of memory concerns among individuals classified as SCD at baseline was associated with increased risk for transition to aMCI or dementia as compared to those with unstable memory concerns across time points (Wolfsgruber et al., 2016).”
BackgroundNumbers, K. T., Lam, B. C. P., Crawford, J. D., Kochan, N. A., Sachdev, P. S., & Brodaty, H. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1044807 · Cited by 12
“And though our investigation into longitudinal stability of SCCs does not directly replicate the methodology of studies (Roehr et al., 2016; Wolfsgruber et al., 2016) cited in the updated SCD-plus framework presented by Jessen and colleagues (Jessen et al.”
BackgroundResultInfluentialWang, X., Wang, M., Wang, X., Zhou, F., Jiang, J., Liu, H., & Han, Y. (2021) · Brain Imaging and Behavior · doi:10.1007/s11682-021-00558-w · Cited by 10
In multiple facets of subjective memory decline sex moderates memory predictions
Drouin, S. M., McFall, G. P., & Dixon, R. A. (2020) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12089 · Cited by 9
Tanaka, S., Murayama, A., Higuchi, D., Saida, K., & Shinohara, T. (2022) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2022.104841 · Cited by 8
Not all, but specific types of cognitive complaints predict decline to MCI
Jessen, F., & Rodriguez, F. S. (2018) · Neurology · doi:10.1212/wnl.0000000000005872 · Cited by 7
“, SCD at one occasion, no SCD at the subsequent follow-up).(7,8)”
BackgroundSelf-citationSchmicker, M., Frühling, I., Menze, I., Glanz, W., Müller, P., Noesselt, T., & Müller, N. G. (2023) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr220092 · Cited by 9
“SCD patients are at an increased risk of future cognitive decline and of developing MCI or AD [5–7], especially those with consistent worries about their cognitive status who have a four times higher risk compared to individuals without worries [8].”
BackgroundLiew, T. M. (2025) · The Journal of Prevention of Alzheimer s Disease · doi:10.1016/j.tjpad.2025.100123 · Cited by 11
Alterstraumatologie: Multimodale Delirprävention und Verwendung von Augmentationstechniken
Wähnert, D., Roos, A., Glasbrenner, J., Ilting-Reuke, K., Ohrmann, P., Hempel, G., Duning, T., Roeder, N., & Raschke, M. J. (2017) · Der Chirurg · doi:10.1007/s00104-016-0339-2 · Cited by 9
Immigration, Racialization, and Asian American Older Adults’ Cognitive Difficulties
Nguyen, D., Liu, R., & Lee, Y. (2023) · The Journals of Gerontology Series B · doi:10.1093/geronb/gbad109 · Cited by 6
Salisbury, D. L., Warry, Fergen, Cruikshank, Soderlund, & Jacklin, K. M. (2023) · Rural and Remote Health · doi:10.22605/rrh8351 · Cited by 8
Symptomatic Clusters Related to Amyloid Positivity in Cognitively Unimpaired Individuals
Sannemann, L., for the DELCODE Study Group, Bartels, C., Brosseron, F., Büerger, K., Fließbach, K., Freiesleben, S. D., Frommann, I., Glanz, W., Heneka, M. T., et al. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-231335 · Cited by 6
“Aside from objective evidence of subtle transitional cognitive decline, classification into stage 2 may also be based on the subjective report of cognitive decline.”
Self-citationXu, Y. H., Warwick, J., Eramudugolla, R., Huque, M. H., Anstey, K. J., & Peters, R. K. (2022) · European Journal of Ageing · doi:10.1007/s10433-022-00694-2 · Cited by 4
Memory Complaint Is a Surrogate for Memory Decline in the Middle-Aged: A Register-Based Study
Wu, Y.-Y., Hsu, W., Huang, Y.-H., Ho, W.-M., & Chen, Y. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8111900 · Cited by 5
“However, although elderly patients with both SCD and consistent memory complaint showed a higher incidence of dementia [24,25], only a few SCD studies have focused on patients younger than 65 years old [5,26].”
BackgroundChen, G., Liu, C., Yang, K. Y., Li, Y., Sheng, C., Xie, Y., Hu, X., Jiang, J., & Han, Y. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200005 · Cited by 3
Scheidt, S., Gathen, M., Lukas, A., Welle, K., Kohlhof, H., Wirtz, D. C., Burger, C., & Kabir, K. (2020) · Der Unfallchirurg · doi:10.1007/s00113-020-00812-8 · Cited by 3
Lee, H. H., & Kang, Y. (2019) · THE KOREAN JOURNAL OF DEVELOPMENTAL PSYCHOLOGY · doi:10.35574/kjdp.2019.12.32.4.21 · Cited by 4
Combined Influences of Dementia Exposure and Personality on Self-Reported Memory Problems
Mogle, J. A., Hill, N. L., Bell, T. R., Bhargava, S., Bratlee‐Whitaker, E., Wion, R. K., & Tiwari, P. A. (2020) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317519899792 · Cited by 4
“Older adults with normal cognitive performance who report memory problems are over twice as likely to develop dementia when compared to those without SRM problems.(2,3) However, other factors (eg, personality and dementia in first-degree relatives [FDRs]) can also influence memory problem reports.”
BackgroundNeuropsychological predictors of cognitive deterioration in non-demented individuals
Kim, H.-G., Jung, H.-S., Koo, B., & Cheon, E. (2019) · Cognitive Neuropsychiatry · doi:10.1080/13546805.2019.1700105 · Cited by 3
Jiang, L., Zhao, S., Li, T., Liu, J., Zhang, J., Zhang, Z., & Li, X. (2025) · BMC Geriatrics · doi:10.1186/s12877-025-06072-8 · Cited by 1
Numbers, K. T., Lam, B. C. P., Samtani, S., Chander, R. J., Vella, A. S., Sachdev, P. S., & Brodaty, H. (2025) · Diagnostics · doi:10.3390/diagnostics15233073 · Cited by 1
“For instance, Wolfsgruber et al. (2017) found that individuals with high levels of concern about their cognitive decline were at significantly increased risk of progressing to mild cognitive impairment (MCI) and dementia compared to those with lower levels of concern [10].”
Hansen, N., Rentzsch, K., Sagebiel, A., Hirschel, S., Schott, B. H., Fitzner, D., Wiltfang, J., & Bartels, C. (2025) · Behavioural Brain Research · doi:10.1016/j.bbr.2025.115541 · Cited by 1
“The probability of progressive cognitive decline in a patient with SCD presenting amyloid-β pathology is high [45 – 47].”
Logroscino, G., & Battista, P. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819641-0.00008-6 · Cited by 1
Erratum zu: Herausforderungen des Entlassmanagements in der Alterstraumatologie
Scheidt, S., Gathen, M., Lukas, A., Welle, K., Kohlhof, H., Wirtz, D. C., Burger, C., & Kabir, K. (2020) · Der Unfallchirurg · doi:10.1007/s00113-020-00837-z
Huang, Y. H., Jia, H., & Bao, W. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816475-4.00013-6 · Cited by 1
Meta-Trends in the Holistic Care of Older Adults
Hyer, L. A., Lee, L., Maginga, S., & Robinson, J. S. (2018) · Open Journal of Geriatrics · doi:10.22259/2639-359x.0101006
Novel perspectives from existing data on early Alzheimer’s disease pathology and dementia care use
Janssen, O. (2022) · Research Publications (Maastricht University) · doi:10.26481/dis.20220617oj
Salisbury, D. L., Warry, W., Soderlund, P. D., Cruikshank, K. R., Fergen, J. T., & Jacklin, K. M. (2024) · Journal of Clinical Exercise Physiology · doi:10.31189/2165-6193-13.3.69
Sannemann, L., Schild, A.-K., Altenstein, S., Bartels, C., Brosseron, F., Büerger, K., Cosma, N. C., Fließbach, K., Freiesleben, S. D., Glanz, W., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13106433
Self-citationSubjective cognition trajectories, Alzheimer biomarkers, and incident mild cognitive impairment
Kuhn, E., Kleineidam, L., Stark, M., Peters, O., Hellmann‐Regen, J., Preis, L., Gref, D., Priller, J., Spruth, E. J., Gemenetzi, M., et al. (2026) · The Journal of Prevention of Alzheimer s Disease · doi:10.1016/j.tjpad.2026.100609
“Most prior studies have relied on binary, retrospective measures of symptom persistence (e.g., yes/no responses), which may overlook subtle or gradual changes [15,16].”
Self-citationAPOE in subjective cognitive decline: a systematic review and meta-analysis
Alonge, P., Baiamonte, L., Gerardi, G., Angelo, T., Mauro, E. L., Veronese, N., Labate, A., & Monastero, R. (2026) · Journal of Neurology · doi:10.1007/s00415-026-14077-5
“…have shown that APOE ε4 is associated with a higher risk of progression and greater changes in cerebrospinal fluid (CSF) and plasma biomarkers, [55, 61, 62, 64, 66] with the exceptions of Zhen Liu et al. and Sierra-Rio et al., who reported no association between APOE status and the…”
Metadata
- Authors
- Wolfsgruber, S., for the AgeCoDe Study Group, Kleineidam, L., Wagner, M., Mösch, E., Bickel, H., Lϋhmann, D., Ernst, A., Wiese, B., Steinmann, S., König, H.-H., Brettschneider, C., Luck, T., Stein, J., Weyerer, S., Werle, J., Pentzek, M., Fuchs, A., Maier, W., Scherer, M., Riedel-Heller, S. G., & Jessen, F.
- Affiliations
- University of Bonn (DE)
- Technical University of Munich (DE)
- University Medical Center Hamburg-Eppendorf (DE)
- Department of Primary Medical Care, Center for Psychosocial Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
- Medizinische Hochschule Hannover (DE)
- Leipzig University (DE)
- Heidelberg University (DE)
- Heinrich Heine University Düsseldorf (DE)
- Institute of General Practice, Medical Faculty, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany
- University of Cologne (DE)
- Corresponding author
- Wolfsgruber, Steffen
- ORCID
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2016-10-04
- Volume
- 54
- Issue
- 3
- Pages
- 1135-1146
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- OpenAlex
- W2510669400
- Cited by
- 94
- References
- 44
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 3 · 2023: 5 · 2022: 12 · 2021: 14 · 2020: 25 · 2019: 10 · 2018: 10 · 2017: 6
- FWCI
- 7.70
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Alzheimer s Disease (publishedVersion)
- PubMed (publishedVersion)
- Kölner Universitäts PublikationsServer (Universität zu Köln) (publishedVersion)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- DZNE Pub (submittedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- subjective cognitive decline, Alzheimer's dementia
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Diagnosis, Differential, Female, Follow-Up Studies, Humans, Longitudinal Studies, Male, Risk Factors, Cohort Studies, Incidence, Cognitive Dysfunction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.